Novo Nordisk sues Eli Lilly for false advertising

cheaperseeker said:


Exactly! I was having bad side effects at 2.5 mg of sema. I certainly wouldn't want to know what they would be like at 7.2 mg.

Click to expand...
I guess those test subjects were mostly reevaluating their will to live while losing weight.
 
Semaglutide 7.2mg achieved –18·7% in thelancet study vs s –15·6% for 2.4mg. Neither of which is over 20% that Tirzepatide achieved. 7.2mg is barely better than 2.4mg in Sema but 70·8% had GI sides! Dysaesthesia nearly quadrupled and 6.8% with serious adverse events. Not sure why they want to fight this out in court Tirzepatide does seem like the better medication with more effective weight loss and less side effects.


https://www.thelancet.com/journals/landia/article/PIIS2213-8587(25)00226-8/abstract
 
BrightCandle said:


Semaglutide 7.2mg achieved –18·7% in thelancet study vs s –15·6% for 2.4mg. Neither of which is over 20% that Tirzepatide achieved. 7.2mg is barely better than 2.4mg in Sema but 70·8% had GI sides! Dysaesthesia nearly quadrupled and 6.8% with serious adverse events. Not sure why they want to fight this out in court Tirzepatide does seem like the better medication with more effective weight loss and less side effects.


https://www.thelancet.com/journals/landia/article/PIIS2213-8587(25)00226-8/abstract


Click to expand...
This is why they want to put up a fight:

"Novo and Lilly are locked in a fierce battle for dominance in the U.S. obesity drug market, which analysts expect to be worth more than $100 billion by 2030."

And then there is the rest of the world.
 
BrightCandle said:


Semaglutide 7.2mg achieved –18·7% in thelancet study vs s –15·6% for 2.4mg. Neither of which is over 20% that Tirzepatide achieved. 7.2mg is barely better than 2.4mg in Sema but 70·8% had GI sides! Dysaesthesia nearly quadrupled and 6.8% with serious adverse events. Not sure why they want to fight this out in court Tirzepatide does seem like the better medication with more effective weight loss and less side effects.


https://www.thelancet.com/journals/landia/article/PIIS2213-8587(25)00226-8/abstract


Click to expand...
Thank you for correcting some of these (F*@#!*) middle points in the article.
 
cheaperseeker said:


Exactly! I was having bad side effects at 2.5 mg of sema. I certainly wouldn't want to know what they would be like at 7.2 mg.

Click to expand...
7.2 mg??... Oh god... 🤯🤯
 
Oh Lord…Idk why but this just makes me laugh. But eesh! 7.2mg Sema? Of COURSE people are losing weight—they’re stuck in the bathroom or clutching their stomachs in bed all day—they can’t make it to the kitchen 🤣

eidos said:


Their lawyers must be thrilled about all the money they're going to make.

Click to expand...
There are going to be quite a few lawyers with private islands and mega yachts after this battle!

I’m glad I’m in the gray space so I can just sit back and eat the popcorn





7204bdec400feb28a7cafe479a1d678d6abd7279816071bb7790545ef59c3ecd.gif
 
Even looking at the doses used in the high dose sema studies makes me feel a bit pukey after a year of nausea from 0.8mg of ozempic. Novo is not doing very well, for the simple fact that tirz is a more effective drug with less side effects at the same time, and unfortunately for them 15mg of tirz is still more effective than 7.2mg or even 16mg of sema in the other trial they did. And the side effect rates in the high dose studies were not pretty.
 
I'd be shocked if this actually goes to trial. They'll settle, Lilly will as another line of text to the commercial and that'll be that, the lawsuit is actually great advertising for the higher more efficacious (but more sides obviously) version of Sema.
 
The U.S. is one of only a handful of countries that allow pharmaceutical companies to advertise prescription medicines directly to consumers

Click to expand...
What an odd choice..
 
Back
Top